Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager drugs
1 medication in the FDA established pharmacologic class “Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager”.
| Drug | Type | NDC products |
|---|---|---|
| Kimmtrak Tebentafusp | Rx | 1 |
1 medication in the FDA established pharmacologic class “Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager”.
| Drug | Type | NDC products |
|---|---|---|
| Kimmtrak Tebentafusp | Rx | 1 |